BioIntelliSense Inc., a Golden-based health technology company, on Tuesday launched the commercial availability of a new wearable device that allows for remote patient monitoring.
The medical-grade BioButton Rechargeable device allows for continuous remote monitoring of more than 20 vital signs and biometrics. It has a charge that can last up to 30 days.
The goal of the product is to better track leading indicators of health and allow for early detection and identification of illness and disease.
In August, CEO James Mault told the Denver Business Journal that prior to a product like his, the standard was to send patients home after major surgery with no means of ongoing data collection. It was labor-intensive and costly to have an intermittent in-person collection of routine vital signs by health professionals.
BioIntelliSense’s products are meant to change that. The BioButton Rechargeable provides continuous monitoring with up to 1,440 passive vital sign measurements per day. Those measurements are then collected and analyzed to identify any adverse trends in a patient’s health.
“The BioButton Rechargeable is the easy button for a healthcare workforce in crisis, realizing a new standard in remote care that is effortless for the patient and clinician while allowing providers to scale care without scaling costs," said Mault in a statement.
The BioButton Rechargeable tracks and alerts patients and clinicians on temperature, resting heart rate, respiratory rate, body position, activity levels, gait, infection-like systems and more.
The rechargeable version of the BioButton is the latest addition to the company’s wearable medical devices.
The BioSticker, which received FDA clearance, launched in January 2020. The double-ended on-body sensor was the company’s first product that allowed for remote patient monitoring. For 30 days, a patient can wear the BioSticker on their skin and then send it back to be recycled.
Later in 2020, a coin-sized disposable medical wearable device called the BioButton was launched. Mault told the DBJ that the ease of the disposable option made it simple and appealing to health systems. The new rechargeable option looks the same as the BioButton, but now it can be recharged and reused on-site, without needing to be sent back to the company. Not only is this easier than the BioSticker, but it becomes the most cost-effective option for health systems, providers and insurance companies.
All three have their own remote Bluetooth transmission, sending the data to a patient's smartphone and to their doctor.
"They're all stick on and forget," Mault told DBJ in an interview. "The beauty is the simplicity of it. It takes no more effort than a Band-Aid."
At the end of July, the company had an oversubscribed $45 million Series B financing round, after the Covid-19 pandemic accelerated market demands for the product. The round was led by Chimera and joined by 7wire Technology Partners; Mary Tolan of Chicago Pacific Founders and James Murren, formerly of MGM Resorts International, as well as Pendrell Corporation, Royal Phillips and Fresenius Medical Care International. These parties joined existing investors from their Series A financing: TripleTree Holdings, UCHealth and the CU Healthcare Innovation Fund.
Since then, the company was one of several Colorado companies to present at CES in Las Vegas in early January.
BioIntelliSense has also partnered with several health care systems to help scale the release of the company’s products. In November 2021, Charlotte-based Joerns Healthcare, a health tech and equipment services company, announced it entered into a strategic channel partnership with BioIntelliSense to introduce its products and data services to provider organizations, particularly in the post-acute and long-term care market.
Most recently, on March 2, BioIntelliSense partnered with United Arab Emirates-based Mubadala Health to incorporate the Golden company’s remote care technologies with Mubadala Health’s continuous care model to drive workflow efficiencies and deliver a personalized care experience.
